Home » Topics » Regulatory » Patents

Patents
RSS

New IL-17 modulators discovered at UCB

Oct. 29, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents HBV HBsAg secretion inhibitors

Oct. 29, 2021

New ENPP1 inhibitors discovered at Betta Pharmaceuticals

Oct. 28, 2021

ADAMTS5 inhibitors patented by Shenzhen Salubris Pharmaceuticals

Oct. 28, 2021

Medshine Discovery presents new DNA-dependent protein kinase inhibitors

Oct. 28, 2021

TGF-beta receptor type-1 inhibitors discovered at Theravance Biopharma

Oct. 28, 2021

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

New TYK2 inhibitors synthesized at Eternity Bioscience

Oct. 27, 2021

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

Oct. 27, 2021

Global Blood Therapeutics patents pyruvate kinase activators

Oct. 27, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...